1.Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry.
Kiho YOU ; Sungmin PARK ; Jai Min RYU ; Isaac KIM ; Se Kyung LEE ; Jonghan YU ; Seok Won KIM ; Seok Jin NAM ; Jeong Eon LEE
Journal of Breast Cancer 2017;20(3):297-303
		                        		
		                        			
		                        			PURPOSE: We evaluated the concordance between core needle biopsy (CNB) and surgical specimens on examining intrinsic biological subtypes and receptor status, and determined the accuracy of CNB as a basic diagnostic method. METHODS: We analyzed breast cancer patients with paired CNB and surgical specimen samples during 2014. We used monoclonal antibodies for nuclear staining, and estrogen receptor (ER) and progesterone receptor (PR) status evaluation. A positive test was defined as staining greater than or equal to 1% of tumor cells. Human epidermal growth factor receptor 2 (HER2) was graded by immunohistochemistry and scored as 0 to 3+ according to the recommendations of the American Society of Clinical Oncology/College of American Pathologists. Ki-67 immunostaining was performed using the monoclonal antibody Ki-67, and the results were divided at 10% intervals. The cutoff value for high Ki-67 was defined as 20%. Concordance analysis of ER, PR, HER2, Ki-67, and five intrinsic biological subtypes was performed on CNB and surgical specimens. Statistical analysis for concordance was calculated using κ-tests. RESULTS: We found very good agreement for ER and PR with a concordance of 96.7% for ER (κ=0.903), and 94.3% for PR (κ=0.870). HER2 and Ki-67 showed concordance rates of 84.8% (κ=0.684) and 83.5% (κ=0.647), respectively, which were interpreted as good agreement. Five subgroups analysis showed 85.8% agreement and κ-value of 0.786, also indicating good agreement. CONCLUSION: CNB showed high diagnostic accuracy compared with surgical specimens, and good agreement for ER, PR, HER2, and Ki-67. Our findings reaffirmed the recommendation of CNB as an initial procedure for breast cancer diagnosis, and the assessment of receptor status and intrinsic biological subtypes to determine further treatment plans.
		                        		
		                        		
		                        		
		                        			Antibodies, Monoclonal
		                        			;
		                        		
		                        			Biopsy, Large-Core Needle*
		                        			;
		                        		
		                        			Breast Neoplasms*
		                        			;
		                        		
		                        			Breast*
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Estrogens
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunohistochemistry*
		                        			;
		                        		
		                        			Methods
		                        			;
		                        		
		                        			Receptor, Epidermal Growth Factor
		                        			;
		                        		
		                        			Receptors, Estrogen
		                        			;
		                        		
		                        			Receptors, Progesterone
		                        			
		                        		
		                        	
2.Changes in Inflammatory Cytokines during Rewarming Period of Therapeutic Hypothermia for Post-Cardiac Arrest Patients.
Hui Jai LEE ; Gil Joon SUH ; Woon Yong KWON ; Kyung Su KIM ; Yoon Sun JUNG ; Kyoung Min YOU ; Youchan KYE
Journal of the Korean Society of Emergency Medicine 2016;27(2):173-181
		                        		
		                        			
		                        			PURPOSE: Therapeutic hypothermia is an important treatment strategy for control of the overwhelming inflammatory reactions of cardiac arrest patients. Rapid rewarming is related to poor outcome, however the kinds of inflammatory processes that occur during the rewarming period are not well understood. Our aim in the current study was to evaluate the changes in inflammatory cytokine levels during cardiac arrest patients' rewarming period. METHODS: This study was conducted in an emergency intensive care unit of a tertiary referral hospital. Blood samples were collected on admission (0 h) and 24, 26, 28, and 32 h after return of spontaneous circulation. Eight inflammatory cytokines (E-selectin, soluble ICAM, interleukin-10, interleukin-1ra, interleukin-6, interleukin-8, monocyte chemotactic protein-1, and tumor necrosis factor-α) were measured. RESULTS: Twenty-eight patients were enrolled and completed a protocol of 24 h hypothermia and 8h rewarming. Eight patients were of the good cerebral performance category (CPC) and 20 of the bad. The IL-1Ra level in the good CPC group was statistically changed at 26 (p=0.039) and 28 (p=0.003) but not at 32 h (p=0.632) when compared with the 24 h level. The IL-10 levels of the bad CPC group were decreased at 26 (p=0.017) and 28h (p=0.013) but not at 32 h (p=0.074) when compared with 24 h. None of the other cytokines showed meaningful differences during the rewarming period. CONCLUSION: Change in inflammatory-cytokine-level change during the rewarming period is not significant.
		                        		
		                        		
		                        		
		                        			Chemokine CCL2
		                        			;
		                        		
		                        			Cytokines*
		                        			;
		                        		
		                        			Emergencies
		                        			;
		                        		
		                        			Heart Arrest
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypothermia
		                        			;
		                        		
		                        			Hypothermia, Induced*
		                        			;
		                        		
		                        			Intensive Care Units
		                        			;
		                        		
		                        			Interleukin 1 Receptor Antagonist Protein
		                        			;
		                        		
		                        			Interleukin-10
		                        			;
		                        		
		                        			Interleukin-6
		                        			;
		                        		
		                        			Interleukin-8
		                        			;
		                        		
		                        			Necrosis
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Rewarming*
		                        			;
		                        		
		                        			Tertiary Care Centers
		                        			
		                        		
		                        	
3.Heart-type Fatty Acid Binding Protein as an Adjunct to Cardiac Troponin-I for the Diagnosis of Myocardial Infarction.
Kyung Su KIM ; Hui Jai LEE ; Kyuseok KIM ; You Hwan JO ; Tae Yun KIM ; Jin Hee LEE ; Joong Eui RHEE ; Gil Joon SUH ; Mi Ran KIM ; Christopher C LEE ; Adam J SINGER
Journal of Korean Medical Science 2011;26(1):47-52
		                        		
		                        			
		                        			We hypothesized that when used in combination with cardiac troponins, heart-type fatty acid binding protein (H-FABP) would have greater diagnostic value than conventional markers for the early diagnosis of myocardial infarction (MI). Patients with typical chest pain at a single emergency department were consecutively enrolled. Initial blood samples were drawn for H-FABP, myoglobin, creatine kinase isoenzyme MB (CK-MB), and cardiac troponin-I (cTnI) measurements. MI was defined by serial cTnI measurements. To evaluate the adjunctive role of biochemical markers, we derived and compared logistic regression models predicting MI in terms of their discrimination (area under the receiver operating characteristics curve, AUC) and overall fit (Bayesian information criterion, BIC). Seventy-six of 170 patients were diagnosed as having MI. The AUC of cTnI, H-FABP, myoglobin, and CK-MB were 0.863, 0.827, 0.784, and 0.772, respectively. A logistic regression model using cTnI (P = 0.001) and H-FABP (P < 0.001) had the biggest AUC (0.900) and the best fit determined by BIC. Sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of this model at 30% probability were 81.6%, 80.9%, 4.26, and 0.23, respectively. H-FABP has a better diagnostic value than both myoglobin and CK-MB as an adjunct to cTnI for the early diagnosis of MI.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Area Under Curve
		                        			;
		                        		
		                        			Biological Markers/blood
		                        			;
		                        		
		                        			Chest Pain/complications
		                        			;
		                        		
		                        			Creatine Kinase, MB Form/blood
		                        			;
		                        		
		                        			Early Diagnosis
		                        			;
		                        		
		                        			Fatty Acid-Binding Proteins/*blood
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Myocardial Infarction/complications/*diagnosis
		                        			;
		                        		
		                        			Myoglobin/blood
		                        			;
		                        		
		                        			Point-of-Care Systems
		                        			;
		                        		
		                        			Predictive Value of Tests
		                        			;
		                        		
		                        			Troponin I/*blood
		                        			
		                        		
		                        	
4.Heart-type Fatty Acid Binding Protein as an Adjunct to Cardiac Troponin-I for the Diagnosis of Myocardial Infarction.
Kyung Su KIM ; Hui Jai LEE ; Kyuseok KIM ; You Hwan JO ; Tae Yun KIM ; Jin Hee LEE ; Joong Eui RHEE ; Gil Joon SUH ; Mi Ran KIM ; Christopher C LEE ; Adam J SINGER
Journal of Korean Medical Science 2011;26(1):47-52
		                        		
		                        			
		                        			We hypothesized that when used in combination with cardiac troponins, heart-type fatty acid binding protein (H-FABP) would have greater diagnostic value than conventional markers for the early diagnosis of myocardial infarction (MI). Patients with typical chest pain at a single emergency department were consecutively enrolled. Initial blood samples were drawn for H-FABP, myoglobin, creatine kinase isoenzyme MB (CK-MB), and cardiac troponin-I (cTnI) measurements. MI was defined by serial cTnI measurements. To evaluate the adjunctive role of biochemical markers, we derived and compared logistic regression models predicting MI in terms of their discrimination (area under the receiver operating characteristics curve, AUC) and overall fit (Bayesian information criterion, BIC). Seventy-six of 170 patients were diagnosed as having MI. The AUC of cTnI, H-FABP, myoglobin, and CK-MB were 0.863, 0.827, 0.784, and 0.772, respectively. A logistic regression model using cTnI (P = 0.001) and H-FABP (P < 0.001) had the biggest AUC (0.900) and the best fit determined by BIC. Sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of this model at 30% probability were 81.6%, 80.9%, 4.26, and 0.23, respectively. H-FABP has a better diagnostic value than both myoglobin and CK-MB as an adjunct to cTnI for the early diagnosis of MI.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Area Under Curve
		                        			;
		                        		
		                        			Biological Markers/blood
		                        			;
		                        		
		                        			Chest Pain/complications
		                        			;
		                        		
		                        			Creatine Kinase, MB Form/blood
		                        			;
		                        		
		                        			Early Diagnosis
		                        			;
		                        		
		                        			Fatty Acid-Binding Proteins/*blood
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Myocardial Infarction/complications/*diagnosis
		                        			;
		                        		
		                        			Myoglobin/blood
		                        			;
		                        		
		                        			Point-of-Care Systems
		                        			;
		                        		
		                        			Predictive Value of Tests
		                        			;
		                        		
		                        			Troponin I/*blood
		                        			
		                        		
		                        	
5.Benign Lesions with Posterior Acoustic Shadowing on Ultrasound: The Pathologic Correlation.
Ju Hee MOON ; Jai Kyung YOU ; Jung Hyun YOON ; Min Jung KIM ; Jin Young KWAK ; Eun Kyung KIM
Journal of the Korean Society of Medical Ultrasound 2009;28(2):93-102
		                        		
		                        			
		                        			A breast lesion with posterior acoustic shadowing is often encountered on sonography and this finding is generally accepted as a sign of malignancy. Although its detection is important for differentiating a malignant breast mass from a benign breast mass, posterior acoustic shadowing is the result of attenuation of the sound beam by a desmoplastic host response to breast cancer rather than the posterior acoustic shadowing being due to the tumor itself. Therefore, many breast conditions that contain fibrous elements also can induce some degree of acoustic shadowing. In this article, we present various benign breast lesions that display posterior acoustic shadowing and we discuss the radiologic findings along with the pathologic correlation.
		                        		
		                        		
		                        		
		                        			Acoustics
		                        			;
		                        		
		                        			Breast
		                        			;
		                        		
		                        			Breast Neoplasms
		                        			;
		                        		
		                        			Shadowing (Histology)
		                        			
		                        		
		                        	
6.Unilateral Breast Edema: Spectrum of Etiologies and Imaging Appearances.
Jin Young KWAK ; Eun Kyung KIM ; Sun Yang CHUNG ; Jai Kyung YOU ; Ki Keun OH ; Yong Hee LEE ; Tae Hee KWON ; Hae Kyoung JUNG
Yonsei Medical Journal 2005;46(1):1-7
		                        		
		                        			
		                        			Breast edema is defined as a mammographic pattern of skin thickening, increased parenchymal density, and interstitial marking. It can be caused by benign or malignant diseases, as a result of a tumor in the dermal lymphatics of the breast, lymphatic congestion caused by breast, lymphatic drainage obstruction, or by congestive heart failure. Here we describe several conditions, that cause unilateral breast edema with the aim of familiarizing radiologists with these disease entities.
		                        		
		                        		
		                        		
		                        			Breast Diseases/*etiology/*radiography/ultrasonography
		                        			;
		                        		
		                        			Edema/*etiology/*radiography/ultrasonography
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			*Mammography
		                        			;
		                        		
		                        			Ultrasonography, Mammary
		                        			
		                        		
		                        	
7.Cellular characteristics of primary and immortal canine embryonic fibroblast cells.
Seungkwon YOU ; Jai Hee MOON ; Tae Kyung KIM ; Sung Chan KIM ; Jai Woo KIM ; Du Hak YOON ; Sungwook KWAK ; Ki Chang HONG ; Yun Jaie CHOI ; Hyunggee KIM
Experimental & Molecular Medicine 2004;36(4):325-335
		                        		
		                        			
		                        			Using normal canine embryonic fibroblasts (CaEF) that were shown to be senescent at passages 7th-9th, we established two spontaneously immortalized CaEF cell lines (designated CGFR-Ca-1 and -2) from normal senescent CaEF cells, and an immortal CaEF cell line by exogenous introduction of a catalytic telomerase subunit (designated CGFR-Ca-3). Immortal CGFR- Ca-1, -2 and -3 cell lines grew faster than primary CaEF counterpart in the presence of either 0.1% or 10% FBS. Cell cycle analysis demonstrated that all three immortal CaEF cell lines contained a significantly high proportion of S-phase cells compared to primary CaEF cells. CGFR-Ca-1 and -3 cell lines showed a loss of p53 mRNA and protein expression leading to inactivation of p53 regulatory function, while the CGFR-Ca-2 cell line was found to have the inactive mutant p53. Unlike the CGFR-Ca-3 cell line that down-regulated p16INK4a mRNA due to its promoter methylation but had an intact p16INK4a regulatory function, CGFR-Ca-1 and -2 cell lines expressed p16INK4a mRNA but had a functionally inactive p16INK4a regulatory pathway as judged by the lack of obvious differences in cell growth and phenotype when reconstituted with wild-type p16INK4a. All CGFR-Ca-1, -2 and -3 cell lines were shown to be untransformed but immortal as determined by anchorage-dependent assay, while these cell lines were fully transformed when overexpressed oncogenic H-rasG12V. Taken together, similar to the nature of murine embryo fibroblasts, the present study suggests that normal primary CaEF cells have relatively short in vitro lifespans and should be spontaneously immortalized at high frequency.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Catalytic Domain/genetics
		                        			;
		                        		
		                        			*Cell Aging/genetics
		                        			;
		                        		
		                        			Cell Line, Transformed
		                        			;
		                        		
		                        			Cell Transformation, Neoplastic
		                        			;
		                        		
		                        			Dogs
		                        			;
		                        		
		                        			Embryo/cytology
		                        			;
		                        		
		                        			Fibroblasts/*cytology/metabolism
		                        			;
		                        		
		                        			Gene Expression
		                        			;
		                        		
		                        			Protein p16/genetics
		                        			;
		                        		
		                        			Protein p53/genetics
		                        			;
		                        		
		                        			RNA, Messenger/analysis/metabolism
		                        			;
		                        		
		                        			Research Support, Non-U.S. Gov't
		                        			;
		                        		
		                        			Telomerase/genetics/metabolism
		                        			;
		                        		
		                        			ras Proteins/genetics/metabolism
		                        			
		                        		
		                        	
8.The Clinical and Histopathological Study of Ota's Nevus.
Seung Hyun CHUN ; Sanghoon LEE ; Hana PARK ; Su Young JHUN ; In Bum SOHN ; Hak Yong KIM ; Eung Ho CHOI ; Sang Min HWANG ; Seung Hun LEE ; Joong Gie KIM ; Seong Jun SEO ; Joo Heung LEE ; Hyun CHUNG ; Sang Won KIM ; Jeong Deuk LEE ; Young Min PARK ; Hyung Ok KIM ; Bo Kyung KOH ; Il Hwan KIM ; Soo Nam KIM ; Seok Jong LEE ; You Chan KIM ; Mi Woo LEE ; Jai Kyoung KOH ; Kwang Ho KIM ; Sang Tae KIM ; Kee Suck SUH ; Sung Ku AHN
Korean Journal of Dermatology 2004;42(3):272-280
		                        		
		                        			
		                        			BACKGROUND: Ota's nevus, characterized by the presence of melanocytes in the dermis, has been familiar among dermatologists, but the etiology, the pathophysiology, the clinical and histological classification are not entirely clear. To understand and elucidate them, more clinical studies and researches are necessary. OBJECT: The aim of this study was to document the clinical and histopathological features of Ota's nevus. METHODS: We examined 299 patients with Ota's nevus who visited the dermatology clinic in Korea from February 1993 to August 2003. Among them, 188 patients were biopsied. All the specimens were stained with hematoxylin and eosin. We examined the age & sex distribution, age of onset, seasonal variation, associated skin diseases, aggravating factors and color. We clinically classified Ota's nevus into 4 types according to Tanino's classification and histologically into 5 types based on the pattern of pigmentation. RESULTS: 1. The ratio of male and female was 1: 3. 2. The peak age of onset was at birth (28.4%) and puberty (24.8%). 3. Seasonal variation was observed with distinct aggravation in the summer (60%). 4. The associated diseases were 9 cases of persistent mongolian spot, 6 cases of nevus flameus, 4 cases of blue nevus, 3 cases of vitiligo, 3 cases of nevus of Ito, 2 cases of atopic dermatitis, 2 cases of psoriasis, 2 cases of cafe au late macules and 2 cases of contact dermatitis. 5. The aggravating factors were sunlight (35.8%), emotional stress (21.0%), menstruation (12.6%), cold exposure (9.5%), pregnancy (9.5%), fatigue (9.5%) and chemical agents (2.1%). 6. The color of lesions were blue black (36.8%), brown (34.8%), dark brown (16.1%) and slate (11.0%). 7. All cases were classified according to Tanino's METHODS: type Ia (23.1%), type Ib (20.1%), type II (26.7%), type III (9.4%), type IV (20.7%). 8. The histological subtypes of Ota's nevus were classified as: the superficial type (35.6%); the middermis type (5.9%), the superficial-middermis type (18.6%); the mid-lower dermis type (2.7%); the diffuse type was composed of the superficial dominant type (19.7%), the middermis dominant type (4.8%), the dispersed (true diffuse) type (12.2%) and the deep dominant type (0.5%). 9. In the relation between histological types and the color of the lesion: the superficial type had 31 cases of brown color, 15 cases of blue black color, 11 cases of dark brown color and 9 cases of slate color; the middermis type had 6 cases of blue black color and 2 cases of dark brown color, query number of cases of slate color; the superficial-middermis type had 12 cases of blue black color, 10 cases of dark brown color, 7 cases of brown color and 6 cases of slate color: the mid-lower dermis type had 3 cases of blue black color; for the diffuse type, the superficial dominant type had 13 cases of brown color, query number of cases of blue black color and 7 cases of dark brown color; the mid-dermis dominant type had 4 cases of brown color, query number of cases of dark brown color, the dispersed type had 14 cases of blue black color and 5 cases of brown color; the deep dominant type had 1 case of blue black color. CONCLUSION: The histological reclassification of Ota's nevus may be very useful in making a therapeutic prognosis of the disease.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Age of Onset
		                        			;
		                        		
		                        			Classification
		                        			;
		                        		
		                        			Dermatitis, Atopic
		                        			;
		                        		
		                        			Dermatitis, Contact
		                        			;
		                        		
		                        			Dermatology
		                        			;
		                        		
		                        			Dermis
		                        			;
		                        		
		                        			Eosine Yellowish-(YS)
		                        			;
		                        		
		                        			Fatigue
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Hematoxylin
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Melanocytes
		                        			;
		                        		
		                        			Menstruation
		                        			;
		                        		
		                        			Mongolian Spot
		                        			;
		                        		
		                        			Nevus
		                        			;
		                        		
		                        			Nevus of Ota*
		                        			;
		                        		
		                        			Nevus, Blue
		                        			;
		                        		
		                        			Parturition
		                        			;
		                        		
		                        			Pigmentation
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Psoriasis
		                        			;
		                        		
		                        			Puberty
		                        			;
		                        		
		                        			Seasons
		                        			;
		                        		
		                        			Sex Distribution
		                        			;
		                        		
		                        			Skin Diseases
		                        			;
		                        		
		                        			Stress, Psychological
		                        			;
		                        		
		                        			Sunlight
		                        			;
		                        		
		                        			Vitiligo
		                        			
		                        		
		                        	
9.Clinical and Histopathological Study of Cutaneous Lymphomas in Korea.
Mi Woo LEE ; Jai Kyoung KOH ; Kyung Sool KWON ; Nack In KIM ; Sang Won KIM ; Soo Nam KIM ; Bang Soon KIM ; You Chan KIM ; Jong Min KIM ; Ki Bum MYUNG ; Jang Kyu PARK ; Kee Suck SUH ; Sook Ja SON ; Eun Sup SONG ; Kwang Hyun CHO ; Baik Kee CHO ; Chee Won OH ; Young Ho WON ; Tae Young YOON ; Kyu Suk LEE ; Seok Jong LEE ; Young Suk LEE ; Won Soo LEE ; Eil Soo LEE ; Chull Wan IHM ; Kyoung Ae JANG ; Sung Nam CHANG ; Jeong Hee HAHM
Korean Journal of Dermatology 2003;41(1):48-57
		                        		
		                        			
		                        			BACKGROUND: The relative frequency and clinicopathologic characteristics of lymphomas vary according to geography and race. Data on the features of cutaneous lymphoma in Korea are limited. OBJECTIVE: The aim of this study was to document the relative occurrence, the clinical and histopathological features of cutaneous lymphomas in Korea. METHODS: The Korean Dermatopathology Research Group conducted a review of nationwide collection of 80 cutaneous lymphomas, diagnosed at 23 institutes over recent 3-year period. Clinical records and pathology slides of the patients were reviewed retrospectively. RESULTS AND CONCLUSION: Korea has a higher rate of T-cell lymphoma and NK/T cell lymphoma and a much lower rate of cutaneous B cell lymphoma. The relative frequency of the major diagnostic group according to WHO classification was as follows: mycosis fungoides/Sezary syndrome, 42.5%; anaplastic large cell lymphoma, 19%; nasal and nasal type NK/T cell lymphoma, 15%; subcutaneous panniculitis-like T cell lymphoma, 11%; peripheral T cell lymphoma, unspecified, 7.5%; follicular lymphoma, 3%; marginal zone lymphoma, 1%; angioimmunoblastic lymphadenopathy, 1%. Compared with Western countries, the rate of nasal and nasal-type NK/T cell lymphoma and subcutaneous panniculitis-like T cell lymphoma were much higher. Therefore, The EORTC classification is not effective in dealing with Korean cases of cutaneous lymphoma. We consider the principles of the WHO classification are applicable to the Korean cases of cutaneous lymphoma.
		                        		
		                        		
		                        		
		                        			Academies and Institutes
		                        			;
		                        		
		                        			Classification
		                        			;
		                        		
		                        			Continental Population Groups
		                        			;
		                        		
		                        			Geography
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoblastic Lymphadenopathy
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Lymphoma*
		                        			;
		                        		
		                        			Lymphoma, B-Cell
		                        			;
		                        		
		                        			Lymphoma, Follicular
		                        			;
		                        		
		                        			Lymphoma, Large-Cell, Anaplastic
		                        			;
		                        		
		                        			Lymphoma, T-Cell
		                        			;
		                        		
		                        			Lymphoma, T-Cell, Peripheral
		                        			;
		                        		
		                        			Pathology
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
10.Clinical and Histopathological Study of Cutaneous Melanoma in Korea.
Mi Woo LEE ; Jai Kyoung KOH ; Kyung Sool KWON ; Nack In KIM ; Sang Won KIM ; Soo Nam KIM ; Bang Soon KIM ; You Chan KIM ; Jong Min KIM ; Ki Bum MYUNG ; Jang Kyu PARK ; Kee Suck SUH ; Sook Ja SON ; Eun Sup SONG ; Kwang Hyun CHO ; Baik Kee CHO ; Chee Won OH ; Young Ho WON ; Tae Young YOON ; Kyu Suk LEE ; Seok Jong LEE ; Young Suk LEE ; Won Soo LEE ; Eil Soo LEE ; Chull Wan IHM ; Kyoung Ae JANG ; Sung Nam CHANG ; Jeong Hee HAHM
Korean Journal of Dermatology 2003;41(1):43-47
		                        		
		                        			
		                        			BACKGROUND: Malignant melanoma in Korea has been increasing as in other countries, but there is no nationwide survey of malignant melanoma in Korea. OBJECTIVE: The aim of this study was to document the clinical and histopathological features of cutaneous melanoma in Korea. METHODS: The Dermatopathology Research Group conducted a review of nationwide collection of 109 primary cutaneous melanomas, diagnosed at 23 institutes over a recent 3-year period. Clinical records and pathology slides of the patients were reviewed retrospectively. RESULTS AND CONCLUSION: The peak age was the 7th decade with the mean age of 58.1 years. Korea has a higher rate of acral melanoma and much lower rate of lentigo maligna melanoma. .Major component tumor cell was spindle cell type. Clark level of tumor was III or more and Breslow depth was 2mm or more at the time of the first diagnosis in many cases (62%). Pre-existing melanocytic nevus was present in a few cases (3 cases). All these features suggest that the racial difference between the Korean and the Caucasian is evident. We also suggest that an early detection program is very important to cure this malignant tumor.
		                        		
		                        		
		                        		
		                        			Academies and Institutes
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hutchinson's Melanotic Freckle
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Melanoma*
		                        			;
		                        		
		                        			Nevus, Pigmented
		                        			;
		                        		
		                        			Pathology
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail